Evaluation of the immunotoxicity and allergenicity of a new intranasal influenza vector vaccine against tuberculosis carrying TB10.4 and HspX antigens
Objective(s): A new vaccine candidate TB/FLU-05E has been developed at the Smorodintsev Research Institute of Influenza (Russia). The vaccine is based on the attenuated influenza strain A/PR8/NS124-TB10.4-2A-HspX that expresses mycobacterial antigens TB10.4 and HspX. This article describes the resul...
Main Authors: | Kira Stosman, Andrei Aleksandrov, Konstantin Sivak, Zhanna Buzitskaya, Marina Stukova |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2023-05-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | https://ijbms.mums.ac.ir/article_21917_9a46bd2eb5e2b8a16f1d684b1e87f609.pdf |
Similar Items
-
Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against <i>Mycobacterium tuberculosis</i> in Mice and Guinea Pigs
by: Mariia Sergeeva, et al.
Published: (2021-04-01) -
Enhancement of the Local CD8<sup>+</sup> T-Cellular Immune Response to <i>Mycobacterium tuberculosis</i> in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens
by: Kirill Vasilyev, et al.
Published: (2021-11-01) -
Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis.
by: Jorge Castro-Garza, et al.
Published: (2017-01-01) -
Comparison of hspX gene sequence in the Beijing and non-Beijing Mycobacterium tuberculosis
by: Ashkan Seyed Majidi, et al.
Published: (2020-12-01) -
Humoral response to HspX and GlcB to previous and recent infection by <it>Mycobacterium tuberculosis</it>
by: Oelemann Walter, et al.
Published: (2007-12-01)